These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8027992)

  • 1. Cyclic GMP phosphodiesterase inhibitors. 2. Requirement of 6-substitution of quinazoline derivatives for potent and selective inhibitory activity.
    Takase Y; Saeki T; Watanabe N; Adachi H; Souda S; Saito I
    J Med Chem; 1994 Jun; 37(13):2106-11. PubMed ID: 8027992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic GMP phosphodiesterase inhibitors. 1. The discovery of a novel potent inhibitor, 4-((3,4-(methylenedioxy)benzyl)amino)-6,7,8-trimethoxyquinazoline.
    Takase Y; Saeki T; Fujimoto M; Saito I
    J Med Chem; 1993 Nov; 36(24):3765-70. PubMed ID: 8254606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta.
    Lugnier C; Schoeffter P; Le Bec A; Strouthou E; Stoclet JC
    Biochem Pharmacol; 1986 May; 35(10):1743-51. PubMed ID: 2423089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of potent cyclic GMP phosphodiesterase inhibitors. 2-Pyridyl- and 2-imidazolylquinazolines possessing cyclic GMP phosphodiesterase and thromboxane synthesis inhibitory activities.
    Lee SJ; Konishi Y; Yu DT; Miskowski TA; Riviello CM; Macina OT; Frierson MR; Kondo K; Sugitani M; Sircar JC
    J Med Chem; 1995 Sep; 38(18):3547-57. PubMed ID: 7658441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine.
    Souness JE; Brazdil R; Diocee BK; Jordan R
    Br J Pharmacol; 1989 Nov; 98(3):725-34. PubMed ID: 2480168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
    Souness JE; Diocee BK; Martin W; Moodie SA
    Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photoaffinity labelling of cyclic GMP-inhibited phosphodiesterase (PDE III) in human and rat platelets and rat tissues: effects of phosphodiesterase inhibitors.
    Tang KM; Jang EK; Haslam RJ
    Eur J Pharmacol; 1994 Jun; 268(1):105-14. PubMed ID: 7925608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 8-(4-Chlorophenyl)thio-cyclic AMP is a potent inhibitor of the cyclic GMP-specific phosphodiesterase (PDE VA).
    Connolly BJ; Willits PB; Warrington BH; Murray KJ
    Biochem Pharmacol; 1992 Dec; 44(12):2303-6. PubMed ID: 1335252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A selective type V phosphodiesterase inhibitor, E4021, dilates porcine large coronary artery.
    Saeki T; Adachi H; Takase Y; Yoshitake S; Souda S; Saito I
    J Pharmacol Exp Ther; 1995 Feb; 272(2):825-31. PubMed ID: 7853200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Benzylamino-1-chloro-6-substituted phthalazines: synthesis and inhibitory activity toward phosphodiesterase 5.
    Watanabe N; Kabasawa Y; Takase Y; Matsukura M; Miyazaki K; Ishihara H; Kodama K; Adachi H
    J Med Chem; 1998 Aug; 41(18):3367-72. PubMed ID: 9719589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells.
    Lugnier C; Schini VB
    Biochem Pharmacol; 1990 Jan; 39(1):75-84. PubMed ID: 2153383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and effects of methyl-2- (4-aminophenyl)-1, 2-dihydro-1-oxo-7- (2-pyridinylmethoxy)-4-(3,4, 5-trimethoxyphenyl)-3-isoquinoline carboxylate sulfate (T-1032), a novel potent inhibitor of cGMP-binding cGMP-specific phosphodiesterase (PDE5).
    Kotera J; Fujishige K; Michibata H; Yuasa K; Kubo A; Nakamura Y; Omori K
    Biochem Pharmacol; 2000 Nov; 60(9):1333-41. PubMed ID: 11008127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
    Torphy TJ; Cieslinski LB
    Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-(3-Chloro-4-methoxybenzyl)aminophthalazines: synthesis and inhibitory activity toward phosphodiesterase 5.
    Watanabe N; Adachi H; Takase Y; Ozaki H; Matsukura M; Miyazaki K; Ishibashi K; Ishihara H; Kodama K; Nishino M; Kakiki M; Kabasawa Y
    J Med Chem; 2000 Jun; 43(13):2523-9. PubMed ID: 10891111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
    Lavan BE; Lakey T; Houslay MD
    Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue.
    Price B; Pyne NJ; Houslay MD
    Biochem Pharmacol; 1987 Dec; 36(23):4047-54. PubMed ID: 2825712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes.
    Méry PF; Pavoine C; Pecker F; Fischmeister R
    Mol Pharmacol; 1995 Jul; 48(1):121-30. PubMed ID: 7623766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KF31327, a new potent and selective inhibitor of cyclic nucleotide phosphodiesterase 5.
    Hirose R; Okumura H; Yoshimatsu A; Irie J; Onoda Y; Nomoto Y; Takai H; Ohno T; Ichimura M
    Eur J Pharmacol; 2001 Nov; 431(1):17-24. PubMed ID: 11716838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of effect of zaprinast on methacholine-induced contraction and inositol 1,4,5-trisphosphate accumulation in bovine tracheal smooth muscle.
    Chilvers ER; Giembycz MA; Challiss RA; Barnes BJ; Nahorski SR
    Br J Pharmacol; 1991 May; 103(1):1119-25. PubMed ID: 1652339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.